Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancer Immunology, Immunotherapy ; 55 (2006), 12. - S. 1524-1533. - ISSN 0340-7004. - eISSN 1432-0851
- Klassifikation
-
Biowissenschaften, Biologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Konstanz
- (wer)
-
Bibliothek der Universität Konstanz
- (wann)
-
2006
- Urheber
-
Waeckerle-Men, Ying
Uetz-von Allmen, Edith
Fopp, Markus
Moos, Roger von
Böhme, Christel
Schmid, Hans-Peter
Ackermann, Daniel
Cerny, Thomas
Ludewig, Burkhard
Groettrup, Marcus
Gillessen, Silke
- URN
-
urn:nbn:de:bsz:352-221156
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Waeckerle-Men, Ying
- Uetz-von Allmen, Edith
- Fopp, Markus
- Moos, Roger von
- Böhme, Christel
- Schmid, Hans-Peter
- Ackermann, Daniel
- Cerny, Thomas
- Ludewig, Burkhard
- Groettrup, Marcus
- Gillessen, Silke
- Bibliothek der Universität Konstanz
Entstanden
- 2006
Ähnliche Objekte (12)
Current status of dendritic cell-based tumor vaccination
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
On the Role of the Immunoproteasome in Protein Homeostasis
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Current status of dendritic cell-based tumor vaccination
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
On the Role of the Immunoproteasome in Protein Homeostasis
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Current status of dendritic cell-based tumor vaccination
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
On the Role of the Immunoproteasome in Protein Homeostasis